首页> 外文期刊>British Journal of Cancer >Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett|[rsquo]|s oesophageal adenocarcinoma
【24h】

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett|[rsquo]|s oesophageal adenocarcinoma

机译:巴雷特食管腺癌中基质溶素(MMP-7)和金属弹性蛋白酶(MMP-12)及其抑制剂TIMP-1和TIMP-3的上调和差异表达

获取原文
获取外文期刊封面目录资料

摘要

Oesophageal adenocarcinoma is believed to arise from metaplastic mucosa in the distal oesophagus, a condition also known as Barrett's oesophagus (BE). BE develops as a result of injury caused by refluxing gastric and duodenal contents and is associated with increased risk of malignant transformation. Matrix metalloproteinases (MMPs) have been implicated in all aspects of tumour progression; tumour growth, basement membrane degradation, invasion and metastatic spread. Using in situ hybridization, we investigated the expression patterns of collagenases-1 and -3, stromelysin-2, matrilysin, metalloelastase and TIMPs-1 and -3 in BE, adenocarcinoma and lymph-node metastases. Matrilysin was expressed abundantly in 12/15 tumours and in 4/6 lymph-node metastases and its expression correlated with the histological aggressiveness of tumour. Matrilysin and metalloelastase were upregulated already in BE. Stromelysin-2 and collagenase-3 expression was detected only in a few tumours. Collagenase-1 was expressed by cancer and stromal cells in 9/15 tumours. Tumour-infiltrating macrophages expressed metalloelastase in 13/15 cancers. TIMPs-1 and -3 were expressed in 12/15 and 11/15 tumours, respectively. Laminin-5 and tenascin were abundantly expressed at the invasive front of poorly differentiated tumours, but not in BE. Our results indicate that matrilysin is the principal MMP expressed by tumour cells in oesophageal adenocarcinoma, and further studies are needed to investigate whether matrilysin or tenascin-C could be used as a predictive marker for progression of BE to cancer. ? 2001 Cancer Research Campaign
机译:食道腺癌被认为是由食管远端的化生性粘膜引起的,这种情况也被称为巴雷特食管(BE)。 BE是由于胃和十二指肠内容物回流引起的损伤而发展的,并且与恶性转化的风险增加相关。基质金属蛋白酶(MMPs)已涉及肿瘤进展的所有方面。肿瘤生长,基底膜降解,侵袭和转移扩散。使用原位杂交,我们研究了BE,腺癌和淋巴结转移中胶原酶-1和-3,基质溶酶2,基质溶素,金属弹性蛋白酶和TIMPs-1和-3的表达模式。基质溶素在12/15肿瘤和4/6淋巴结转移中大量表达,其表达与肿瘤的组织学侵袭性相关。在比利时,胃泌素和金属弹性蛋白酶已被上调。仅在少数肿瘤中检测到了stromelysin-2和胶原酶3的表达。胶原酶-1在9/15肿瘤中由癌症和基质细胞表达。肿瘤浸润巨噬细胞在13/15癌症中表达了金属弹性蛋白酶。 TIMPs-1和-3分别在12/15和11/15肿瘤中表达。 Laminin-5和Tenascin在分化较差的肿瘤的浸润前部大量表达,而在BE中则没有。我们的结果表明,胃溶素是食管腺癌中肿瘤细胞表达的主要MMP,还需要进一步研究以研究胃溶素或腱生蛋白C可以用作BE向癌症进展的预测标志物。 ? 2001年癌症研究运动

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号